CIK 0001818794
- Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364883909
- Phone
- +1 781-786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $40,000
- in 1 filing
- Open-market sales, last 90 days
- $421,679
- in 7 filings, $422K under 10b5-1 plans
Net −$381,679. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-05 | Lubner David Charles Director | Grant or award · Stock option (right to buy) | +35,152 | 35,152 | ||
| 2026-04-24 | Lubner David Charles Director | Gift | −53,625 | 0 | ||
| 2025-05-30 | Lubner David Charles Director | Grant or award · Stock option (right to buy) | +35,000 | 35,000 | ||
| 2024-05-22 | Lubner David Charles Director | Grant or award · Stock option (right to buy) | +25,133 | 25,133 | ||
| 2023-05-24 | Lubner David Charles Director | Grant or award · Stock Option (right to buy) | +24,900 | 24,900 | ||
| 2022-07-05 | Lubner David Charles Director | Grant or award · Stock Option (right to buy) | +7,222 | 7,222 | ||
| 2022-06-03 | Lubner David Charles Director | Grant or award · Stock Option (right to buy) | +19,596 | 19,596 | ||
| 2021-05-26 | Lubner David Charles Director | Grant or award · Stock Option (right to buy) | +19,596 | 19,596 | ||
| 2020-09-21 | Lubner David Charles Director | Conversion | +53,625 | 53,625 | ||
| 2020-09-21 | Lubner David Charles Director | Conversion · Series B Preferred Stock | −177,872 | 0 | ||
| 2020-08-07 | Lubner David Charles Director | Purchase · Series B Preferred Stock | +177,872 | $2.81 | $500K | 177,872 |
| 2020-07-31 | Lubner David Charles Director | Grant or award · Stock Option (right to buy) | +11,156 | 11,156 | ||
| 2020-07-31 | Lubner David Charles Director | Grant or award · Stock Option (right to buy) | +14,444 | 14,444 |
Page 1 of 1 · 13 trades